Precipio Reminder of Corporate Update Shareholder Call
May 01 2019 - 6:06PM
Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), will
host a conference call on Monday, May 6th, 2019 at 5:00pm Eastern
Time to review recent company and business events, and provide a
corporate update. During the call, management will discuss the
recent reverse split and the timing rationale; we will also be
joined by Ori Karev, Precipio’s recently hired Chief Strategy
Officer, who will share some thoughts on the company’s vision for
global expansion.
The conference call may be accessed by calling 1-844-695-5519
(international callers may dial 1-412-902-6760). All callers should
ask for the Precipio Inc. conference call. Participants may also
pre-register for the conference call
at http://dpregister.com/10130839 and will receive a calendar
invite and a direct dial-in number, bypassing the operator.
Listeners interested in submitting questions in advance should
email their questions to investors@precipiodx.com and management
will do its best to address those questions during the call.
A replay of the call will be available approximately 24 hours
after the call and may be accessed via the Investors page on
Precipio’s website, http://www.precipiodx.com/investors.html.
About Precipio
Precipio has built a platform designed to
eradicate the problem of misdiagnosis by harnessing the intellect,
expertise and technology developed within academic institutions and
delivering quality diagnostic information to physicians and their
patients worldwide. Through its collaborations with world-class
academic institutions specializing in cancer research, diagnostics
and treatment such as the Yale School of Medicine and Harvard’s
Dana-Farber Cancer Institute, Precipio offers a new standard of
diagnostic accuracy enabling the highest level of patient care. For
more information, please visit www.precipiodx.com.
Forward-Looking Statements
Certain statements in this press release constitute
“forward-looking statements,” within the meaning of federal
securities laws including financial projections related thereto and
potential market opportunity, plans and prospects and other
statements containing the words “anticipate,” “intend,” “may,”
“plan,” “predict,” “will,” “would,” “could,” “should,” and similar
expressions, constitute forward-looking statements within the
meaning of The Private Securities Litigation Reform Act of 1995.
The Company's actual results could differ materially from those
anticipated in these forward-looking statements as a result of
various factors. Factors that could cause future results to
materially differ from the recent results or those projected in
forward-looking statements include the known risks, uncertainties
and other factors described in the Definitive Proxy filed by the
Company on April 29, 2019 and the Company’s Annual Report on Form
10-K for the year ended December 31, 2018 as filed on April 16,
2019 as well as the Company’s prior filings and from time to time
in the Company’s subsequent filings with the Securities and
Exchange Commission. Any change in such factors, risks and
uncertainties may cause the actual results, events and performance
to differ materially from those referred to in such statements. All
information in this press release is as of the date of the release
and the Company does not undertake any duty to update this
information, including any forward-looking statements, unless
required by law.
Inquiries:
investors@precipiodx.com
+1-203-787-7888
Precipio (NASDAQ:PRPO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Precipio (NASDAQ:PRPO)
Historical Stock Chart
From Apr 2023 to Apr 2024